BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6211360)

  • 1. Effect of medroxyprogesterone acetate on DMBA-induced rat mammary carcinoma and on immunological reactivity.
    Spreafico F; Filippeschi S; Malfiore C; Noseda S; Falautano P; Serraglia N
    Eur J Cancer Clin Oncol; 1982 Jan; 18(1):45-51. PubMed ID: 6211360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of medroxyprogesterone acetate (MPA) and the pure antiestrogen EM-219 on estrone (E1)-stimulated growth of dimethylbenz(a)anthracene (DMBA)-induced mammary carcinoma in the rat.
    Li S; Lévesque C; Geng CS; Yan X; Labrie F
    Breast Cancer Res Treat; 1995 May; 34(2):147-59. PubMed ID: 7647332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combined therapies with medroxyprogesterone acetate (MPA) in DMBA-induced rat mammary cancer].
    Ishikawa H; Iino Y; Izuo M; Takikawa H
    Gan No Rinsho; 1986 Feb; 32(2):151-5. PubMed ID: 2937941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenic activity of rat mammary carcinomas induced by 7,12-dimethylbenz[a]anthracene and its inhibition by medroxyprogesterone acetate: possible involvement of antiangiogenic action of medroxyprogesterone acetate in its tumor growth inhibition.
    Oikawa T; Hiragun A; Yoshida Y; Ashino-Fuse H; Tominaga T; Iwaguchi T
    Cancer Lett; 1988 Dec; 43(1-2):85-92. PubMed ID: 2462464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition by 9alpha-fluoromedoroxyprogesterone acetate (FMPA) against mammary carcinoma induced by dimethylbenz[a]anthracene in rats and angiogenesis in the rabbit cornea - comparison with medroxyprogesterone acetate (MPA).
    Uchida M; Tsuboi H; Yamaji T; Murata N; Kohno T; Sugino E; Hibino S; Shimamura M; Oikawa T
    Cancer Lett; 2000 Jun; 154(1):63-9. PubMed ID: 10799740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in rats.
    Zaccheo T; Casazza AM; di Salle E; Pollini C; di Marco A
    Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1193-7. PubMed ID: 6236980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
    Dauvois S; Spinola PG; Labrie F
    Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental study of combination medical endocrine therapy on DMBA-induced mammary tumor, with special reference to the effect of drug-dose on various factors].
    Kosaka A; Yamashita A
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):75-81. PubMed ID: 1530907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential hormone therapy with medroxyprogesterone acetate for 7, 12-dimethylbenz [alpha] anthracene-induced rat mammary tumors.
    Iino Y; Ishikawa H; Izuo M; Takikawa H
    Jpn J Clin Oncol; 1989 Mar; 19(1):45-50. PubMed ID: 2522157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
    Tominaga T; Yoshida Y; Kitamura M; Kosaki G
    Jpn J Cancer Res; 1985 Nov; 76(11):1120-5. PubMed ID: 2935517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of medroxyprogesterone acetate on the response of the rat mammary gland to carcinogenesis.
    Russo IH; Gimotty P; Dupuis M; Russo J
    Br J Cancer; 1989 Feb; 59(2):210-6. PubMed ID: 2522791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
    Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F
    Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medroxyprogesterone acetate accelerates the development and increases the incidence of mouse mammary tumors induced by dimethylbenzanthracene.
    Aldaz CM; Liao QY; LaBate M; Johnston DA
    Carcinogenesis; 1996 Sep; 17(9):2069-72. PubMed ID: 8824536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of medroxyprogesterone acetate on DMBA-induced mammary tumors.
    Racca S; Conti G; Crispino A; Gallo E; Di Carlo F
    Chemioterapia; 1985 Jun; 4(3):236-8. PubMed ID: 3928182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of medroxyprogesterone acetate antineoplastic activity by histidine in rat mammary tumours.
    Di Carlo F; Conti G; Giubertoni M; Muccioli G; Racca S
    Cancer Chemother Pharmacol; 1991; 27(4):271-7. PubMed ID: 1825621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and synthetic progestins accelerate 7,12-dimethylbenz[a]anthracene-initiated mammary tumors and increase angiogenesis in Sprague-Dawley rats.
    Benakanakere I; Besch-Williford C; Schnell J; Brandt S; Ellersieck MR; Molinolo A; Hyder SM
    Clin Cancer Res; 2006 Jul; 12(13):4062-71. PubMed ID: 16818706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophysectomy and injections of high doses of estrogens inhibit the growth of ovary-independent rat mammary carcinomas.
    Nomura S; Yoshida H; Kaneko Y
    In Vivo; 1990; 4(2):121-5. PubMed ID: 1966585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of medroxyprogesterone acetate (MPA) on phosphodiesterase (PDE) activity in DMBA-induced rat mammary tumours.
    Racca S; Squillario P; Carozzi S; Bedino S; Testore G; Giubertoni M; Di Carlo F
    Pharmacol Res; 1989; 21(1):101-2. PubMed ID: 2542917
    [No Abstract]   [Full Text] [Related]  

  • 19. Curcumin delays development of medroxyprogesterone acetate-accelerated 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
    Carroll CE; Benakanakere I; Besch-Williford C; Ellersieck MR; Hyder SM
    Menopause; 2010; 17(1):178-84. PubMed ID: 19629015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of the progesterone antagonists ZK 98.299 and RU 38.486 in the hormone-dependent MXT mammary tumor model of the mouse and the DMBA- and the MNU-induced mammary tumor models of the rat.
    Schneider MR; Michna H; Nishino Y; el Etreby MF
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):691-701. PubMed ID: 2497018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.